• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER; OCCLUDER, PATENT DUCTUS, ARTERIOSUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER; OCCLUDER, PATENT DUCTUS, ARTERIOSUS Back to Search Results
Model Number 9-PDA-003
Device Problem Migration or Expulsion of Device (1395)
Patient Problems Hemorrhage/Bleeding (1888); Foreign Body Embolism (4439)
Event Date 02/16/2022
Event Type  malfunction  
Event Description
Situation: an infant with congenital heart and lung disease was sent to the catheterization laboratory for hemodynamic assessment and possible intervention.There were complications during the case requiring surgical intervention and extracorporeal membrane oxygenation (ecmo).Background: patient is an infant with a genetic lung mutation (filamin a), pulmonary hypertension, congenital heart disease (vsd, asd, pda (patent ductus arteriosus (pda) - heart defect)), and biventricular dysfunction, who was intubated since birth, and had a prior ecmo course at the referring facility.He was transferred for high-risk lung or heart-lung transplantation evaluation, possible tracheostomy, and possible surgical or transcatheter intervention on his heart defects.As a part of this transplant evaluation he was sent to the catheter lab for hemodynamic assessment, vasoreactivity testing, and possible pda closure.Following diagnostic testing in the catheter lab, there was a multidisciplinary discussion with the pulmonary hypertension, icu, surgery, and catheter lab teams.There was agreement that primary surgical closure of the defects had intolerable risk, and plan was to proceed with transcatheter pda closure followed by more aggressive medical ph (pulmonary hypertension) therapy.Assessment: after the pda device was placed, the device embolized to the aorta.During attempted transcatheter device retrieval, there was injury to the right iliac vein.Surgical intervention was required to control bleeding and to retrieve the embolized device.The patient was brought back to the icu on ecmo support.This device was disposed.Case reviewed - no deviations from generally accepted practice standards identified.Thoughtful consideration of risks before and during procedure, appropriate response to procedural complication with thoughtful interdisciplinary discussion and decision making.Device migration is a known complication and is discussed during pre-procedural consult with family.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER
Type of Device
OCCLUDER, PATENT DUCTUS, ARTERIOSUS
Manufacturer (Section D)
ABBOTT MEDICAL
26531 ynez road
temecula CA 92591
MDR Report Key13677682
MDR Text Key286650132
Report Number13677682
Device Sequence Number1
Product Code MAE
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/07/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model Number9-PDA-003
Device Catalogue Number9-PDA-003
Device Lot Number7538185
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA03/03/2022
Date Report to Manufacturer03/07/2022
Type of Device Usage Unknown
Patient Sequence Number1
Patient Age60 DA
Patient SexMale
-
-